rs72549154

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_139125.4(MASP1):​c.1727G>T​(p.Arg576Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0422 in 1,613,940 control chromosomes in the GnomAD database, including 2,259 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.067 ( 608 hom., cov: 33)
Exomes 𝑓: 0.040 ( 1651 hom. )

Consequence

MASP1
NM_139125.4 missense

Scores

1
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.00400

Publications

12 publications found
Variant links:
Genes affected
MASP1 (HGNC:6901): (MBL associated serine protease 1) This gene encodes a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response. The encoded protein is synthesized as a zymogen and is activated when it complexes with the pathogen recognition molecules of lectin pathway, the mannose-binding lectin and the ficolins. This protein is not directly involved in complement activation but may play a role as an amplifier of complement activation by cleaving complement C2 or by activating another complement serine protease, MASP-2. The encoded protein is also able to cleave fibrinogen and factor XIII and may may be involved in coagulation. A splice variant of this gene which lacks the serine protease domain functions as an inhibitor of the complement pathway. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
MASP1 Gene-Disease associations (from GenCC):
  • 3MC syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • 3MC syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020614266).
BP6
Variant 3-187236144-C-A is Benign according to our data. Variant chr3-187236144-C-A is described in ClinVar as Benign. ClinVar VariationId is 1166550.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MASP1NM_139125.4 linkc.1727G>T p.Arg576Met missense_variant Exon 11 of 11 ENST00000296280.11 NP_624302.1 P48740-2
MASP1NM_001879.6 linkc.1303+5337G>T intron_variant Intron 10 of 15 ENST00000337774.10 NP_001870.3 P48740-1
MASP1NR_033519.2 linkn.1600G>T non_coding_transcript_exon_variant Exon 10 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MASP1ENST00000296280.11 linkc.1727G>T p.Arg576Met missense_variant Exon 11 of 11 1 NM_139125.4 ENSP00000296280.7 P48740-2
MASP1ENST00000337774.10 linkc.1303+5337G>T intron_variant Intron 10 of 15 1 NM_001879.6 ENSP00000336792.5 P48740-1

Frequencies

GnomAD3 genomes
AF:
0.0674
AC:
10255
AN:
152154
Hom.:
608
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.150
Gnomad AMI
AF:
0.0186
Gnomad AMR
AF:
0.0415
Gnomad ASJ
AF:
0.0412
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.0978
Gnomad FIN
AF:
0.0442
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0319
Gnomad OTH
AF:
0.0603
GnomAD2 exomes
AF:
0.0452
AC:
11312
AN:
250456
AF XY:
0.0456
show subpopulations
Gnomad AFR exome
AF:
0.150
Gnomad AMR exome
AF:
0.0270
Gnomad ASJ exome
AF:
0.0381
Gnomad EAS exome
AF:
0.000871
Gnomad FIN exome
AF:
0.0400
Gnomad NFE exome
AF:
0.0324
Gnomad OTH exome
AF:
0.0380
GnomAD4 exome
AF:
0.0396
AC:
57871
AN:
1461668
Hom.:
1651
Cov.:
81
AF XY:
0.0404
AC XY:
29405
AN XY:
727162
show subpopulations
African (AFR)
AF:
0.156
AC:
5218
AN:
33480
American (AMR)
AF:
0.0283
AC:
1267
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0371
AC:
970
AN:
26136
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39700
South Asian (SAS)
AF:
0.0879
AC:
7578
AN:
86258
European-Finnish (FIN)
AF:
0.0399
AC:
2122
AN:
53196
Middle Eastern (MID)
AF:
0.0225
AC:
130
AN:
5768
European-Non Finnish (NFE)
AF:
0.0342
AC:
38040
AN:
1112010
Other (OTH)
AF:
0.0419
AC:
2530
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
4011
8023
12034
16046
20057
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1540
3080
4620
6160
7700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0674
AC:
10264
AN:
152272
Hom.:
608
Cov.:
33
AF XY:
0.0673
AC XY:
5010
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.150
AC:
6213
AN:
41530
American (AMR)
AF:
0.0415
AC:
635
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0412
AC:
143
AN:
3468
East Asian (EAS)
AF:
0.00154
AC:
8
AN:
5184
South Asian (SAS)
AF:
0.0975
AC:
471
AN:
4830
European-Finnish (FIN)
AF:
0.0442
AC:
469
AN:
10606
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0319
AC:
2170
AN:
68032
Other (OTH)
AF:
0.0597
AC:
126
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
462
923
1385
1846
2308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0415
Hom.:
716
Bravo
AF:
0.0703
TwinsUK
AF:
0.0410
AC:
152
ALSPAC
AF:
0.0415
AC:
160
ESP6500AA
AF:
0.139
AC:
611
ESP6500EA
AF:
0.0333
AC:
286
ExAC
AF:
0.0473
AC:
5742
Asia WGS
AF:
0.0660
AC:
230
AN:
3478
EpiCase
AF:
0.0308
EpiControl
AF:
0.0309

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24023860) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

3MC syndrome 1 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
6.4
DANN
Benign
0.87
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.52
T;T
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-0.96
T
PhyloP100
0.0040
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-2.0
N;N
REVEL
Benign
0.21
Sift
Uncertain
0.0040
D;D
Sift4G
Benign
0.089
T;T
Polyphen
0.011
B;B
Vest4
0.092
MPC
0.13
ClinPred
0.016
T
GERP RS
-0.34
gMVP
0.53
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72549154; hg19: chr3-186953932; API